ArticleClinical case reports2019
Brentuximab vedotin as monotherapy for unresectable breast implant-associated anaplastic large cell lymphoma.
Anthony Stack et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it